Cargando…
Making pharmaceutical research and regulation work for women
The legacy of male bias within pharmaceutical research, regulation, and commercialisation needs to be rectified, argue Sundari Ravindran and colleagues
Autores principales: | Ravindran, TK Sundari, Teerawattananon, Yot, Tannenbaum, Cara, Vijayasingham, Lavanya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587233/ https://www.ncbi.nlm.nih.gov/pubmed/33109511 http://dx.doi.org/10.1136/bmj.m3808 |
Ejemplares similares
-
Universal access: making health systems work for women
por: Ravindran, TK Sundari
Publicado: (2012) -
Acting on sex and gender in medical innovation is good for business
por: Vijayasingham, Lavanya, et al.
Publicado: (2023) -
Employment based health financing does not support gender equity in universal health coverage
por: Vijayasingham, Lavanya, et al.
Publicado: (2020) -
Self care interventions for sexual and reproductive health and rights: costs, benefits, and financing
por: Remme, Michelle, et al.
Publicado: (2019) -
To include or not include: renal dialysis policy in the era of universal health coverage
por: Teerawattananon, Yot, et al.
Publicado: (2020)